Affiliation: | 1. Cardiovascular Risk Intervention Program, Center for Experimental Therapeutics and Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA;1. Cardiovascular Division, Royal Postgraduate Medical School, London, England UK;1. From the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA |